Evaluation of synthetic schemes to prepare immunogenic conjugates of Vibrio cholerae O139 capsular polysaccharide with chicken serum albumin

Glycoconjugate Journal

Volumn 17, Issue 6, 2000, Pages 425-433

  Kossaczka, Z ^a   Szu, S C ^a  

^a EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

Author keywords

Cholera O139 vaccine; O139 capsular polysaccharide; Vibrio cholerae O139; Vibriocidal activity to serotype O139

Indexed keywords

1 (3 DIMETHYLAMINOPROPYL) 3 ETHYLCARBODIIMIDE; 4 AMINOPYRIDINE DERIVATIVE; ADIPIC ACID DERIVATIVE; ANTIBODY CONJUGATE; BACTERIAL POLYSACCHARIDE; CHOLERA VACCINE; DIPHTHERIA TOXIN; DRUG CARRIER; HYDRAZIDE DERIVATIVE; SERUM ALBUMIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL MEMBRANE; BACTERIAL VIRULENCE; BACTERIOLYSIS; CHOLERA; CONTROLLED STUDY; DRUG CONJUGATION; DRUG SYNTHESIS; FEMALE; IMMUNOGENICITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; SEROTYPE; VIBRIO CHOLERAE;

ADIPIC ACIDS; ANIMALS; ANTIBODIES, BACTERIAL; BLOOD BACTERICIDAL ACTIVITY; CARBOHYDRATE SEQUENCE; CHICKENS; CHOLERA VACCINES; IMMUNOCONJUGATES; IMMUNOGLOBULIN G; MICE; MOLECULAR SEQUENCE DATA; POLYSACCHARIDES, BACTERIAL; SERUM ALBUMIN; VACCINES, CONJUGATE; VACCINES, SYNTHETIC; VIBRIO CHOLERAE;

ANIMALIA; BACTERIA (MICROORGANISMS); GALLUS GALLUS; VIBRIO CHOLERAE;

EID: 0034463949     PISSN: 02820080     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1007164216202     Document Type: Article

References (23)

1. Epidemiology & molecular biology of Vibrio cholerae O139 Bengal
2. Molecular analysis of toxigenic Vibrio cholerae O139 Bengal strains isolated in Bangladesh between 1993 and 1996: Evidence for emergence of a new clone of the Bengal vibrios
3. Emergence of a new cholera pandemic: Molecular analysis of virulence determinants in Vibrio cholerae O139 and development of a live vaccine prototype
4. Morphological and physical characterization of the capsular layer of Vibrio cholerae O139
5. The Vibrio cholerae O139 serogroup antigen includes an O-antigen capsule and lipopolysaccharide virulence determinants
6. Vibrio cholerae O139 Bengal possesses a capsular polysaccharide which may confer increased virulence
7. Structure of the capsular polysaccharide of Vibrio cholerae O139 synonym Bengal containing D-galactose-4,5-cyclophosphate
8. Preliminary structure determination of the capsular polysaccharide of Vibrio cholerae O139 Bengal Al1837
9. Comparison of immune responses in patients infection with Vibrio cholerae O139 and O1
10. Vibriocidal antibody responses in North American volunteers exposed to wild-type or vaccine Vibrio cholerae O139: Specificity and relevance to immunity
11. Serum antibacterial and antitoxin responses in clinical cholera caused by Vibrio cholerae O139 Bengal and evaluation of their importance in protection
12. Antigenicity of dextran-protein conjugates
13. Activation of soluble polysaccharides with 1-cyano-4-dimethyl-aminopyridinium tetrafluoroborate (CDAP) for use in protein-polysaccharide conjugate vaccines and immunological reagents. II. Selective crosslinking of proteins to CDAP-activated polysaccharides
14. Colonial opacity variations among the choleragenic vibrios
15. Vibrio cholerae O139 conjugate vaccines: Synthesis and immunogenicity in mice of the V. cholerae O139 capsular polysaccharide conjugates with recombinant diphtheria toxin mutant
16. Synthesis, characterization and immunological properties in mice of conjugates composed of detoxified lipopolysaccharide of Salmonella paratyphi A bound to tetanus toxoid, with emphasis on the role of O-acetyls
17. Synthesis and immunological properties of Vi and Di-O-acetyl pectin protein conjugates with adipic acid dihydrazide as the linker
18. 3,6-dideoxyhexoses
19. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding
20. The derivatization of cross-linked polyacylamide beads. Controlled induction of functional groups for the purpose of special biochemical absorbents
21. U.S. Department of Health and Human Services, Public Health service, Food and Drug Administration Guideline on validation of the limulus amebocyte lysate test as an end-product endotoxin test for human and animal parenteral drugs